Source: Respiratory physiology & neurobiology. Unidade: FM
Subjects: TRANSPLANTE DE MEDULA ÓSSEA (IMUNOLOGIA), ASMA (TERAPIA), COLÁGENO, CÉLULAS-TRONCO (TRANSPLANTE), FATORES DE CRESCIMENTO, CAMUNDONGOS, MODELOS ANIMAIS
ABNT
ABREU, Soraia C et al. Bone marrow mononuclear cell therapy in experimental allergic asthma: Intratracheal versus intravenous administration. Respiratory physiology & neurobiology, v. 185, n. 3, p. 615\2013624, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.resp.2012.11.005. Acesso em: 05 nov. 2024.APA
Abreu, S. C., Antunes, M. A., Maron-Gutierrez, T., Fernanda F Cruz,, Ornellas, D. S., Silva, A. L., et al. (2013). Bone marrow mononuclear cell therapy in experimental allergic asthma: Intratracheal versus intravenous administration. Respiratory physiology & neurobiology, 185( 3), 615\2013624. doi:10.1016/j.resp.2012.11.005NLM
Abreu SC, Antunes MA, Maron-Gutierrez T, Fernanda F Cruz, Ornellas DS, Silva AL, Diaz BL, Ab'Saber AM, Capelozzi VL, Xisto DG, Morales MM, Rocco PRM. Bone marrow mononuclear cell therapy in experimental allergic asthma: Intratracheal versus intravenous administration [Internet]. Respiratory physiology & neurobiology. 2013 ; 185( 3): 615\2013624.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.resp.2012.11.005Vancouver
Abreu SC, Antunes MA, Maron-Gutierrez T, Fernanda F Cruz, Ornellas DS, Silva AL, Diaz BL, Ab'Saber AM, Capelozzi VL, Xisto DG, Morales MM, Rocco PRM. Bone marrow mononuclear cell therapy in experimental allergic asthma: Intratracheal versus intravenous administration [Internet]. Respiratory physiology & neurobiology. 2013 ; 185( 3): 615\2013624.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.resp.2012.11.005